Lexicon Pharmaceuticals LXRX Interest Paid, Excluding Capitalized Interest, Operating Activity
Interest Paid, Excluding Capitalized Interest, Operating Activity at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's interest paid, excluding capitalized interest, operating activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Lexicon Pharmaceuticals (LXRX) reported interest paid, excluding capitalized interest, operating activity of $1.48M in Q1 2026.
- How has Lexicon Pharmaceuticals's interest paid, excluding capitalized interest, operating activity changed year-over-year?
- Lexicon Pharmaceuticals's interest paid, excluding capitalized interest, operating activity decreased by 50.2% year-over-year, from $2.97M to $1.48M.
- What is the long-term trend for Lexicon Pharmaceuticals's interest paid, excluding capitalized interest, operating activity?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's interest paid, excluding capitalized interest, operating activity has grown at a 79.7% compound annual growth rate (CAGR), from $799K to $8.33M.